Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-20T19:35:31.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:16:24.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:11:05.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-30T06:09:24.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T02:22:39.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has removed references to the Open-Label Surufatinib study in European patients with neuroendocrine tumors.
    Difference
    0.2%
    Check dated 2025-05-15T21:23:57.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.